Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[EM]

What are you trying to say?

GHP owns 6,8% stake in Kitov's equity after TyrNovo deal.

Basically they accepted to be paid in shares. Would you accept to be paid in shares if you didn't know that:

1. they will fund the company operations you sold;

2. Financial safety of the company you will take 6,8% stake;

3. Potential of the company and of its lead drug candidate to increase equity value.

I think that GHP did more DD than everyone else in the planet before accepting (more than Kunhil). Better than any speculative institutional investors.

NT219 is not a simple asset, they didn't sell peanuts. Years of research for a very promising drug (founder is wolf price awarded Alexander Levitzki).